Martha Thibault is the Head of Trial Execution Services for Emerging Oncology Biotech at ICON, where they lead operational excellence in clinical development. With over 25 years of experience in hematology and oncology research, Martha has developed a strong expertise in project management and strategic innovation within the biotech industry. They have previously held leadership roles at PPD, Kendle International, and PAREXEL, demonstrating a commitment to fostering collaboration and delivering high-quality results. Martha holds a BA in Biology from the University of North Carolina Wilmington and an MBA from the University of Phoenix, and is currently pursuing a Doctor of Management in Operational Leadership, maintaining a 4.0 GPA.
This person is not in the org chart
This person is not in any teams
This person is not in any offices